Table of Contents  
ORIGINAL ARTICLE
Year : 2017  |  Volume : 11  |  Issue : 1  |  Page : 36-43

Predictor factors of sleep-disordered breathing in heart failure


1 Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Assiut University, Assiut, Egypt
2 Department of Cardiology, Faculty of Medicine, Assiut University, Assiut, Egypt
3 Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt

Date of Submission11-Jul-2016
Date of Acceptance29-Sep-2016
Date of Web Publication24-Jan-2017

Correspondence Address:
Doaa Magdy
Chest Diseases and Sleep Medicine, Chest Department, Faculty of Medicine, Assiut University Hospital, Assiut, 71111
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1687-8426.198988

Rights and Permissions
  Abstract 

Background Heart failure (HF) is characterized by its high mortality, frequent hospitalizations, and reduced quality of life. Sleep-disordered breathing (SDB), one of the common comorbidities, accelerates the progression of HF.
Objectives The objectives of the study were (a) to investigate the prevalence and type of SDB in HF patients and (b) to determine the predictors of SDB.
Materials and methods In a cross-sectional analytic study, all eligible patients of Assiut Chest and Cardiology Department admitted (100 patients) during the period from August 2015 to March 2016 were included in this study. Clinical assessment, full-night attended polysomnography, and echocardiography were recorded and compared between patients with (SDB) (85 patients) and those without SDB (15 patients).
Results SDB was found in 85% of patients [53% had obstructive sleep apnea (OSA) and 32% had central sleep apnea (CSA)]. OSA patients are characterized by higher BMI and neck and waist circumference. There was a higher prevalence of hypertension, as well as mean blood pressure, systolic blood pressure, diastolic blood pressure, in OSA patients. Loud snoring was the only clinical symptom associated with OSA as compared with CSA. CSA patients had a significant reduction in PaCO2. OSA patients showed a significant increase in desaturation index and time spent with oxygen saturation less than 90%. Maximum heart rate and brady/tachy index were significantly increased in OSA. Cycle length was significantly increased in CSA.
Conclusion The prevalence of sleep apnea was high in patients with stable HF (85%). OSA was the predominant type (53%). The predictors of SDB were BMI (≥30), systemic hypertension, neck circumference more than 40 cm, waist circumference more than 110 cm, and ejection fraction (left ventricular ejection fraction) (≤45%).

Keywords: heart failure, polysomnography, predictors


How to cite this article:
Salama S, Omar A, Ahmed Y, El Sabour MA, Seddik MI, Magdy D. Predictor factors of sleep-disordered breathing in heart failure. Egypt J Bronchol 2017;11:36-43

How to cite this URL:
Salama S, Omar A, Ahmed Y, El Sabour MA, Seddik MI, Magdy D. Predictor factors of sleep-disordered breathing in heart failure. Egypt J Bronchol [serial online] 2017 [cited 2024 Mar 28];11:36-43. Available from: http://www.ejbronchology.eg.net/text.asp?2017/11/1/36/198988


  Introduction Top


Heart failure (HF) is a highly prevalent syndrome with an estimated annual incidence of half a million. Despite therapeutic advances in pharmacology, HF remains a leading cause of morbidity, as well as frequent hospitalizations and a reduced quality of life [1]. Sleep-disordered breathing (SDB), one of the most common comorbidities in HF, occurs in 50–80% of patients, and is known to accelerate the progression of the condition, thus increasing morbidity and mortality [2],[3].

The present study aimed (a) to investigate the prevalence and type of SDB in HF patients and (b) to determine the predictors of SDB in HF patients.


  Materials and methods Top


This cross-sectional analytic study was carried out in the Chest and Cardiology Department, Faculty of Medicine, Assiut University Hospital, during the period from August 2015 to March 2016.

The study design was approved by the Scientific Ethics Committee of Faculty of Medicine of Assiut University.

Informed consent was obtained from the patients.

Among 100 patients who were admitted during this period and fulfilled the inclusion criteria, only 85 patients had SDB. Patients were classified into two groups: group 1, the SDB group (85 patients), and group 2, the without SDB (no SDB) group (15 patients). Group 1 patients were further subclassified into those with central sleep apnea (CSA) and those with obstructive sleep apnea (OSA) based on the predominant (>50%) type of sleep apnea.

Exclusion criteria

Patients with recent unstable angina or myocardial infarction within 3 months of the study, those with a history of chronic lung disease (i.e. obstructive pulmonary disease), pregnant woman, those with a history of stroke or clinical signs of peripheral or central nervous system disorders were excluded from the study.

All patients were subjected to a comprehensive clinical assessment, an overnight-attended polysomnography, and echocardiography.

Clinical assessment and sleep history

Clinical data of patients were recorded, including age, sex, anthropometric measures (height, weight, BMI, and neck and waist circumference), history of diabetes mellitus, and history of hypertension. New York Heart Association classification (NYHA) functional classification of HF was determined. The standard HF therapy was noted for each patient (angiotensin-converting enzyme inhibitors, β-blockers, diuretics, and amiodarone). Sleep history was as follows: daytime symptoms included morning headache and excessive daytime sleepiness and night-time symptoms included loud snoring, disturbed sleep rhythm, witnessed apnea, bad dreams, and frequent nocturea). Epworth Sleepiness Score was used in our study. Results of at least 10 are considered to represent significant excessive daytime sleepiness [4].

Echocardiography

All participants underwent transthoracic echocardiography (Vivid S5; GE Healthcare, United States), which was performed in the left lateral decubitus position. Images were obtained in different views (parasternal long-axis as well as apical four chambers, two chambers, and three chambers) according to current standards, by personnel blinded to the results of polysomnography [5].

Left atrial diameter, left ventricular (LV) end-diastolic internal dimension, LV end-systolic internal dimension, interventricular septal thickness, and LV posterior wall thickness were determined from M-mode measurements. In addition, left ventricular ejection fraction (LVEF) was measured according to the modified Simpson’s method using apical four and two chamber views. Right ventricle diameter and pulmonary artery systolic pressure (PASP) were also measured. PASP can be determined using the modified Bernoulli equation: (PASP)=4×(peak TR velocity) 2+RAP.

The maximum velocity of the tricuspid valve regurgitant jet (v) is measured using continuous wave Doppler and added to the estimated right atrial pressure (RAP) [6].

Polysomnography

All patients underwent full-night attended polysomnography (Somnstar 4100; Sensor-Medics Co., Yorba Linda, California, USA) in the sleep laboratory of the Assiut university hospital. The polysomnogram systematically monitors the electroencephalogram (C3–A2, C4–A1), electro-oculogram, electromyogram of the chin, electrocardiogram, body positions, nasal and oral airflow, thoracic and abdominal effort, limb movements, pulse oximetry, and snoring sound level. The polysomnograms were all scored manually according to the American academy of sleep medicine [7].

Cheyne–Stokes respiration

Cheyne–Stokes respiration is defined as three consecutive central apneas and/or central hypopneas separated by a crescendo and decrescendo change in breathing amplitude with a cycle length of at least 40 s and the central apnea index of at least 5 per hour [7]. Cycle length is the duration of the central apnea plus the duration of a respiratory phase. If central hypopneas occur, the cycle length is defined as the time from the zenith in the respiratory phase preceding the central hypopnea to the zenith of the next respiratory phase [7]. Minimum and maximum heart rate was recorded. Brady/tachy index, which is the average number of bradycardia and tachycardia events per hour, was also recorded.

Statistical analysis

Data were analyzed using SPSS (Statistical Package for Social Science), version 16 (IBM Inc., Armonk, NewYork, USA) software was used for analysis of results. The results in this study were expressed as mean±SD or number and percentage. Comparison between two groups was made using the t-test and the one-way analysis of variance test for comparison between more than two groups. The difference was considered significant when P value of less than 0.05. Logistic regression analysis was performed to detect predictors of SDB in HF.


  Results Top


[Table 1] shows demographic data and clinical examination in HF patients with SDB and those no SDB. Group 1 patients with SDB had significantly higher age group, BMI, neck and waist circumference, and serum cholesterol level. Moreover, the prevalence of hypertension, as well as mean blood pressure (MBP), systolic blood pressure (SBP), and diastolic blood pressure (DBP), was significantly increased in patients with SDB.
Table 1 Demographic data and clinical examination findings in heart failure patients with sleep-disordered breathing and those without sleep-disordered breathing

Click here to view


As shown in [Table 2], patients with OSA had a significant increase in BMI and the prevalence of hypertension (MBP, SBP and DBP) as compared with the CSA and the no SDB group. However, cases with CSA recorded a statistically significant difference in age, neck and waist circumference, and serum cholesterol level as compared with the no SDB group.
Table 2 Anthropometric measures, demographic data, and comorbidities among obstructive sleep apnea, central sleep apnea and no sleep-disordered breathing in heart failure patients

Click here to view


As shown in [Table 3], CSA was significantly higher in NYHA functional class (III and IV) as compared with the OSA and the no SDB group. It was observed that the Epworth Sleepiness Scale was significantly higher in OSA patients. OSA patients showed a significant increase in daytime and night-time symptoms of sleep apnea compared with no SDB patients. The prevalence of loud snoring was significantly increased in patients with OSA as compared with CSA patients.
Table 3 Clinical scores for heart failure and sleep disorders between obstructive sleep apnea, central sleep apnea, and no sleep-disordered breathing in heart failure patients

Click here to view


[Table 4] shows that CSA patients had a significant respiratory alkalosis and a decrease in the mean value of PaCO2 associated with marked atrial fibrillation (AF) as compared with OSA and no SDB.
Table 4 Comparison in arterial blood gases and electrocardiography changes between each of obstructive sleep apnea, central sleep apnea, and no sleep-disordered breathing groups with heart failure

Click here to view


As regards polysomnographic parameters ([Table 5]), the respiratory disturbance index (RDI) was significantly increased in OSA patients. Patients with CSA had a significant increase in the Cheyne–Stokes respiration index as well as cycle length when compared with the OSA and the no SDB group.
Table 5 Baseline polysomnographic parameters between obstructive sleep apnea, central sleep apnea, and no sleep-disordered breathing in heart failure patients

Click here to view


As regards respiratory oxygenation during sleep, patients with OSA had a significantly more severe arterial oxyhemoglobin desaturation and time spent with oxygen saturation below 90%. Moreover, a significant reduction in minimum and average oxygen saturation was observed in OSA patients when compared with CSA and no SDB patients. As regards heart rate recording during sleep, OSA patients showed a significant reduction in minimum heart rate and a significant increase in maximum heart rate and brady/tachy index.

As shown in [Table 6], LVEF was significantly reduced in patients with CSA as compared with OSA and no SDB patients. Patients with HF reduced ejection fraction (≤45%) had a significantly higher prevalence of CSA, whereas HF patients with preserved ejection fraction (>45%) had a significantly higher prevalence of OSA.
Table 6 Echocardiographic parameters between each of obstructive sleep apnea, central sleep apnea, and no sleep-disordered breathing

Click here to view


As regards LV dimensions, CSA patients had a significant increase in LV end diastolic and LV end systolic diameter, whereas in patients with OSA, both posterior wall diameter and interventricular septal diameter were significantly increased. There was no significant difference in PASP between both OSA and CSA. OSA was significantly higher in patients with hypertensive heart disease, whereas CSA had a significantly higher prevalence in ischemic heart disease and dilated cardiomyopathy.

[Table 7] shows that the possible predictive factors of SDB in HF were BMI of at least 30, systemic hypertension, neck circumference more than 40 cm, waist circumference more than 110 cm, LVEF (≤45%), NYHA functional class III and IV, AF, male sex, and age more than 50 years.
Table 7 Logistic regression analysis revealing the possible predictors for sleep-disordered breathing in patients with heart failure

Click here to view



  Discussion Top


In the current study, we have studied the prevalence of SDB in HF, and found that 85% of patients with HF had SDB; OSA accounted for 53%, whereas CSA sleep apnea accounted for (32%). Our results are consistent with previous studies. Paulino et al. [8] evaluated 316 French patients with stable HF and found that the prevalence of SDB was high (81%), (70% were classified as having OSA, whereas 30% were classified as having CSA). Moreover, Ferreira and colleagues [9] investigated 103 patients with HF on optimal treatment. SDB was found in 72.8% of patients (60% had OSA and 9.3% had CSA). In another recent study by Damy and colleagues [10], who studied 384 patients with HF, SDB was discovered in 88% of patients (62% had OSA and 26% had CSA). In contrast, previous studies reported a lower prevalence of SDB, with a clear predominance of CSA over OSA. Javaheri and colleagues [11] reported that the prevalence of SDB in 81 outpatients with stable HF was 51% (10% had OSA and 40% had CSA). Moreover, Vazir and colleagues [12] demonstrated that the prevalence of SDB was 53% (15% OSA and 38% CSA). This variability in the reported prevalence of SDB may be attributed to the small number of patients involved, or the use of different monitoring techniques to measure airflow. SDB in those studies was evaluated with cardiorespiratory polygraphy instead of standard polysomonography.

As regards patient characteristics of SDB in HF, we observed that patients with SDB were characterized by old age (56.35±7.23vs. 51.13±4.32 years in no SDB) and male sex (63.5 vs. 36.5%). Similarly, Paulino and colleagues [8] demonstrated that HF patents with SDB had significantly older age group (mean age; 60±13 vs. 55±14 years in no SDB) and male sex (86 vs.67%). Arzt and colleagues [13] also reported a higher prevalence of SDB in men than in women (49 vs. 36%) and also found that the rate of SDB increased as age increased (the prevalence in patients≤50 years was 31%, whereas in those>80 years the prevalence was 59%). The sex-related differences may be attributed to differences in sleep characteristics between the two sexes; men have less stable sleep architecture compared with women, with a greater number of sleep–wake transitions and shorter slow wave sleep, which may predispose to respiratory control system instability and central apneas [14].

Our study revealed that patients with CSA were characterized by significantly old age (61.69±6.93 vs. 53.13±5.27 years in OSA). In accordance with previous studies, Sin and colleagues [15] evaluated the risk factors for CSA and OSA on 450 patients with HF; patients with CSA were older than those with OSA (64.8±11.1 vs. 58.2±12.6 years). Older patients with HF have less compliant left ventricles with higher filling pressures compared with younger ones. This possibly may place them at a higher risk for nocturnal hyperventilation and CSA.

In addition to age and sex, obesity was an important risk factor for the development of SDB in HF. Patients with OSA had a significant increase in the mean BMI (35.50±3.73 vs. 30.97±2.06 kg/m2 in CSA). Paulino and colleagues [8] reported a significant increase in BMI in OSA patients (28.3±5.4 vs. 27.9±5.1 kg/m2 in CSA). Sin and colleagues [15]. also demonstrated higher BMI in patients with OSA (32.3±7.0 vs. 26.3±4.5 kg/m2) than in those with CSA. A possible explanation is that obese individuals frequently have short, thick necks and peripharyngeal fatty deposits that may contribute to pharyngeal obstruction [15]. Herrscher et al. [16] demonstrated that BMI of at least 30 kg/m2 was the only independent predictor of moderate-to-severe SDB in HF patients [odds ratio (OR)=3.62, 95% confidence interval (CI) 1.40–9.36, P=0.008]. Thus, BMI may be used as one of the selection criteria for referral of HF patients to a sleep specialist [16]. In contrast, Friedman et al. [17] reported that OSA was highly prevalent in nonobese patients with HF (mean BMI 30.2±1.3 vs. 33.8±1.3 kg/m2 in HF patients without OSA). This can be attributed to the fact that HF patients often experience varying degrees of chronic fluid overload resulting in redistribution of excess fluid from the legs to the chest and neck when supine during sleep and may predispose to OSA resulting in increased peripharyngeal edema and cervical congestion that compresses the upper airway and obstructs airflow [17].

Our results revealed that neck circumference, which is an indirect measure of fat deposition around the neck has been shown to be an important and independent predictor of SDB among HF patients (42.07±2.50 vs. 39.87±1.51 cm in no SDB). Similarly, Ferreira and colleagues [9], who studied 103 patients with HF to identify the possible risk factors for sleep apnea in HF patients reported that an increased neck circumference has been associated with an increased risk for SDB in HF (41.0 vs. 38.0 cm in no sleep apnea, P=0.003). Moreover, Loo and colleagues [18], who studied 332 HF patients (mean age: 62±10 years) to determine a possible predictor of SDB, demonstrated that neck circumference is one of the predictors of SDB among HF patients (OR=1.06; 95% CI 1.02–1.10; P=0.001). This can be attributed to the fact that increased fat around the neck, related to an android pattern of adiposity, may contribute to pharyngeal narrowing and collapsibility. Another additional mechanism, the redistribution of excess fluid from the legs to the neck during sleep, resulting in increased peripharyngeal edema and cervical congestion, compresses the upper airway and obstructs airflow [19].

Waist circumference is another predictor, which has been found as a risk factor for SDB among HF patients. Our findings are similar to those of Loo and colleagues [18], who found that waist circumference (OR=1.06; 95% CI 1.01–1.13, P=0.001) is one of the independent predictors of SDB among HF patients.

In our study, we observed that the prevalence of systemic hypertension was significantly higher in patients with OSA (62.3 vs. 20.0% in no SDB), with a significant increase in the mean value of SBP, DBP, and MBP. This is in accordance with the findings of Logan and colleagues [20], who demonstrated that, in medically treated patients with HF, the prevalence of systolic hypertension was significantly increased in patients with OSA (83%), with a significant increase in daytime SBP (190.43±43.12 vs. 140.54±23.11 mmHg in no SDB). OSA plays a linking role between hypertension and HF. Intermittent apnea-related hypoxia, as well as the intrathoracic pressure swings and arousals associated with respiratory events, augment sympathetic nervous system activity, which may contribute to elevated blood pressure [21].

On comparing clinical symptoms suggestive of sleep apnea between CSA and OSA, our study revealed that loud snoring was the prevalent night-time symptom in patients with OSA (56 vs. 33.3% as compared with CSA). Similarly, Javaheri and colleagues [21] found that 78% of patients with OSA had nocturnal snoring, and only 28% of patients with CSA had nocturnal snoring. Moreover, Bitter and colleagues [22] investigated more than 1500 HF (LVEF ≤45%, NYHA ≥II) patients for possible symptoms of sleep apnea and found that snoring was the only symptom independently associated with OSA (66 vs. 25%).

In this study, we demonstrated that most predictors of SDB among HF patients were BMI of at least 30, systemic hypertension, neck circumference more than 40 cm, waist circumference (>110 cm), and LVEF (≤45%). Similarly, Loo and colleagues [18] studied 332 HF patients (mean age: 62±10 years) to determine possible predictors of SDB and demonstrated that neck circumference (OR=1.09; 95% CI 1.01–1.12, P=0.002), waist circumference (OR=1.06; 95% CI 1.01–1.13, P=0.001), BMI (OR=1.19; 95% CI 1.10–1.30, P=0.001), and age (OR=1.06; 95% CI 1.02–1.10, P=0.001) were independent predictors of SDB. Moreover, in a large prospective study by Woehrle and colleagues [23], who investigated the prevalence of SDB and its predictors in patients with stable chronic HF, the authors found that HF patients with SDB often do not show characteristic symptoms, suggesting that the presence of one or more predictors of SDB [e.g. male sex (OR=1.90, 95% CI 1.67–2.17)], age more than 60 years (OR=1.41, 95% CI 1.34–1.49), obesity (OR=1.29, 95% CI 1.22–1.36), LVEF less than 25% (OR=1.10, 95% CI 1.06–1.39), and AF (OR=1.19, 95% CI 1.06–1.34) should prompt clinicians to perform device-based screening for SDB.


  Conclusion Top


The prevalence of sleep apnea was high in patients with stable HF despite optimized therapy (85%). OSA was the predominant type (53%). The possible predictive factors of SDB in HF were BMI of at least 30, systemic hypertension, neck circumference more than 40 cm, waist circumference (>110 cm), and LVEF (≤45%).

Acknowledgements

The authors thank all nursing staff in the chest department and the technicians in the sleep laboratory and cardiology department in our hospital and Assiut Faculty of Medicine Research Grants.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Lloyd-Jones D, Adams R, Carnethon M, Simone G, Ferguson TB, Flegal K et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21–e181.  Back to cited text no. 1
    
2.
Kasai T, Bradley D. Obstructive sleep apnea and heart failure. J Am Coll Cardiol 2011; 57:119–127.  Back to cited text no. 2
    
3.
Khayat R, Small R, Rathman L, Steven K, Becky G, Linda C et al. Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients. J Card Fail 2013; 19:431–444.  Back to cited text no. 3
    
4.
Johns M. A new method for measuring day-time sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14:540–541.  Back to cited text no. 4
    
5.
Lang R, Bierig M, Devereux R, Elyse F, Patricia A, Michael H et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79–108.  Back to cited text no. 5
    
6.
Sciomer S, Badagliacca R, Fedele F. Pulmonary hypertension: echocardiographic assessment. Heart J 2005; 6:840–845.  Back to cited text no. 6
    
7.
Berry R, Brooks R, Gamaldo C. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification, version 2.1. Darien, IL: American Academy of Sleep; 2014.  Back to cited text no. 7
    
8.
Paulino A, Damy T, Margarit L et al., Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis 2009; 102:169–175.  Back to cited text no. 8
    
9.
Ferreira S, Anabela M, Marta P, Santa-Clara E, Carrondo C, Winck J et al. Prevalence and characteristics of sleep apnoea in patients with stable heart failure. BMC Pulm Med 2010; 10:9.  Back to cited text no. 9
    
10.
Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 2012; 14:1009–1019.  Back to cited text no. 10
    
11.
Javaheri S, Parker T, Liming J et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalence, consequences, and presentations. Circulation 1998; 97: 2154–2159.  Back to cited text no. 11
    
12.
Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9:243-250.  Back to cited text no. 12
    
13.
Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: The schlahf registry. JACC Heart Fail 2016; 4:116–125.  Back to cited text no. 13
    
14.
Hume KI, Van F, Watson A. A field study of age and gender differences in habitual adult sleep. J Sleep Res 1998; 7:85–94.  Back to cited text no. 14
    
15.
Sin D, Fitzgerald F, Parker J, Newton G, Floras J, Bradley T. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160:1101–1106.  Back to cited text no. 15
    
16.
Herrscher T, Akre H, Overland B, Sandvik L, Westheim AS. Clinical predictors of sleep apnea in heart failure outpatients. Int J Clin Pract 2014; 6:725–730.  Back to cited text no. 16
    
17.
Friedman O, Bradley T, Chan C, Parkes R, Logan A. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 2010; 56:1077–1082.  Back to cited text no. 17
    
18.
Loo G, Chua A, Tay H, Poh R, Tai B, Lee C. Sleep-disordered breathing in cardiac rehabilitation: prevalence, predictors, and influence on the six-minute walk test. Heart Lung Circ 2016; 25:584–591.  Back to cited text no. 18
    
19.
Sin D, Fitzgerald F, Parker D, Newton G, Logan A, Floras J et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003; 123:1536–1543.  Back to cited text no. 19
    
20.
Logan A, Tkacova R, Tisler A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of obstructive sleep apnea in refractory hypertension. J Hypertension 2001; 19:2271–2277.  Back to cited text no. 20
    
21.
Javaheri S, Parker TJ, Liming JD et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97:2154–2159.  Back to cited text no. 21
    
22.
Bitter T, Westerheide N, Hossain S, Prinz C, Horstkotte D, Oldenburg O et al. Symptoms of sleep apnoea in chronic heart failure-results from a prospective cohort study in 1,500 patients. Sleep Breath 2012; 16:781–791.  Back to cited text no. 22
    
23.
Woehrle H, Arzt M, Oldenburg O et al. Prevalence and predictors of sleep disordered breathing in patients with stable chronic heart failure: Final data of the Schla HF Registry; J Am College Cardiol 2015; 65(10S).  Back to cited text no. 23
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Materials and me...
Results
Discussion
Conclusion
References
Article Tables

 Article Access Statistics
    Viewed1206    
    Printed42    
    Emailed0    
    PDF Downloaded91    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]